Aptevo Therapeutics Accounts Payable

Aptevo Therapeutics (APVO) currently reports a accounts payable of $890K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Aptevo Therapeutics's accounts payable history and peer comparisons.

Aptevo Therapeutics's accounts payable changed from $0 to $890K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aptevo Therapeutics reported $890K in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $890K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aptevo Therapeutics, and consider following APVO for alerts when major investors trade the stock.

Aptevo Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $890K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APVO with unrelated industries.